Document is current

Landsburg, Daniel J

Frigault, Matthew J

Heim, Michael

Foley, Stephen Ronan

Hill, Brian

Schofield, Grant

Jacobson, Caron A

Jaglowski, Samantha

Locke, Frederick L

Ram, Ron

Riedell, Peter A

Shah, Gunjan https://orcid.org/0000-0002-9977-0456

Popplewell, Leslie L

Tiwari, Ranjan

Lim, Stephen

Majdan, Marta

Masood, Aisha

Pasquini, Marcelo

Turtle, Cameron J

Clinical trials referenced in this document:

Funding for this research was provided by:

CareDx

St. Baldrick’s Foundation

Kyowa Kirin Pharmaceutical Development

OptumHealth

StemCyte

bluebird bio

Priothera

CRISPR

Kiadis Pharma

PBMTF

Dana-Farber Cancer Institute

Kadmon, a Sanofi Company

Health Resources and Services Administration (HHSH250201700005C)

Health Resources and Services Administration (HHSH250201700006C)

Health Resources and Services Administration (HHSH250201700007C)

Boston Children’s Hospital

Office of Naval Research (N00014-20-1-2832)

Office of Naval Research (N00014-21-1-2954)

Be The Match Foundation

Adienne SA

Allogene Therapeutics

Karius

Actinium Pharmaceuticals

Atara Biotherapeutics

BeiGene

Jazz Pharmaceuticals

Anthem Foundation

Sanofi

Sanofi-Aventis

Sobi, Inc.

Vertex Pharmaceuticals

Talaris Therapeutics

Pharmacyclics, LLC

Orca Biosystems, Inc.

Iovance Biotherapeutics

Pfizer, Inc.

Terumo Blood and Cell Technologies

Xenikos BV

TG Therapeutics

Gilead Sciences

National Heart, Lung, and Blood Institute (OT3HL147741)

National Heart, Lung, and Blood Institute (U01HL128568)

National Heart, Lung, and Blood Institute (U24CA076518)

National Heart, Lung, and Blood Institute (U24HL138660)

National Heart, Lung, and Blood Institute (U24HL157560)

MorphoSys

Miltenyi Biotec, Inc.

Gamida-Cell, Ltd.

Novartis Pharmaceuticals Corporation

Omeros Corporation

National Cancer Institute (U24CA076518)

National Cancer Institute (U24CA233032)

National Cancer Institute (U24HL138660)

National Cancer Institute (U24HL157560)

Ossium Health, Inc.

Medical College of Wisconsin

Fate Therapeutics

AbbVie

Stanford University

ADC Therapeutics

National Marrow Donor Program

Allovir, Inc.

Adaptive Biotechnologies Corporation

Millennium, the Takeda Pharmaceuticals

U.S. Government (P01CA111412)

U.S. Government (R01AI128775)

U.S. Government (R01AI150999)

U.S. Government (R01AI158861)

U.S. Government (R01CA100019)

U.S. Government (R01CA152108)

U.S. Government (R01CA218285)

U.S. Government (R01CA231141)

U.S. Government (R01CA231838)

U.S. Government (R01CA262899)

U.S. Government (R01HL131731)

U.S. Government (R01HL155741)

U.S. Government (SC1MC31881)

U.S. Government (U01AI069197)

U.S. Government (U01AI126612)

U.S. Government (UG1HL06924)

U.S. Government (UM1CA121947)

Astellas Pharma US

AstraZeneca

Bristol Myers Squibb Co.

CSL Behring

CytoSen Therapeutics, Inc.

Eurofins Viracor, DBA Eurofins Transplant Diagnostics

Merck & Co.

Takeda Oncology Co.

GlaxoSmithKline

HistoGenetics

Incyte Corporation

Janssen Research & Development, LLC

Janssen/Johnson & Johnson

Jasper Therapeutics

Legend Biotech

Amgen, Inc.

Mallinckrodt Pharmaceuticals

Kite, a Gilead Company

Medexus Pharma

Magenta Therapeutics

National Institute of Allergy and Infectious Diseases (U24CA076518)

Medac GmbH

License valid from 2025-02-09